Skip to main content
. 2017 Nov 1;20(11):1225–1230. doi: 10.1089/jpm.2016.0487

Table 4.

Rationale for Continuation or De-Escalation of Antithrombotic Therapy as Documented in Patient Medical Record (n = 60)

  n (%)
Reason for continuation (n = 43)
 Not addressed 20 (46.5)
 Active treatment still indicated 15 (34.9)
 Patient/family preference 6 (14.0)
 Palliative 6 (14.0)
 Prophylaxis still indicated 8 (18.6)
 Benefit outweighs risk 1 (3.0)
Reason for De-escalation (n = 17)
 Not addressed 2 (11.8)
 Bleeding risk 10 (58.8)
 Patient/family preference 4 (23.5)
 No indication for prior anticoagulation 3 (17.6)
 New contraindication 2 (11.8)
 More consistent with palliative goals of care 5 (29.4)
 Ease of monitoring 1 (5.9)

Percentages do not sum to 100% because prescribers may have documented more than reason for continuation or de-escalation.